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Abstract The chromatin phospholipid fraction is enriched in
sphingomyelin content which changes during cell maturation
and proliferation. Recently, we have demonstrated that the
sphingomyelin variations can be due to chromatin neutral sphin-
gomyelinase and sphingomyelin-synthase activities which di¡er
in pH and Km optima from those present in nuclear membranes.
The sphingomyelin can be used also as a source of phospho-
rylcholine for phosphatidylcholine synthesis by reverse sphingo-
myelin-synthase. In the present work we have studied the pos-
sible existence of reverse sphingomyelin-synthase activity in
nuclear membrane and chromatin. A very low activity was de-
tected in the homogenate, cytosol and nuclear membrane
(0.93% 0.14, 2.61 % 0.33 and 0.87% 0.13 pmol/mg protein/min,
respectively), whereas the activity present in chromatin was
37.09% 2.05 pmol/mg protein/min. The reverse sphingomyelin-
synthase decreases the intranuclear diacylglycerol pool and in-
creases the intranuclear ceramide pool, whereas sphingomyelin-
synthase has an opposite e¡ect. The possible correlation be-
tween these enzymes is discussed.
0 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Phosphatidylcholine (PC) biosynthesis can occur by Ken-
nedy pathway [1], phosphatidylethanolamine (PE) methyla-
tion [2], lyso-PC acylation [3], base exchange from phospha-
tidylserine (PS) [4], and reverse reaction of sphingomyelin-
synthase (SM-synthase), which utilizes SM as source of phos-
phorylcholine (PCh) [5,6]. In cultured normal human skin
¢broblasts, after incubation with [14C]SM for 17 h, about
65^80% of the cellular radioactivity was recovered in PC [7]
and after incubation with [32P] or methyl-[3H]SM for 20 h,
50% of [3H] and [32P] was recovered in PC [5]. The concen-
tration ratios PC/SM and diacylglycerol (DAG)/ceramide are
intrinsically related, thus providing the cell with a mechanism
for the regulation of PC/SM ratio by varying the DAG/cer-
amide ratio [6]. The reverse reaction of SM-synthase has been
localized to the plasma membrane of Ehrlich ascites cells [6]
and to the basolateral surface of epithelial cells [8]. Recently,
the PC synthesizing enzymes were also described in the nu-
cleus [9^11]. In fact, in several cell types (HepG2, NIH-3T3,
and L-cells) the CTP:phosphocholine cytidyltransferase is as-
sociated with the nuclear envelope [9] ; in CHO cells and he-
patocytes the activity of this enzyme was recovered in the
nuclear fraction, for 76% and 32%, respectively, [10]. In rat
hepatocyte nuclei and isolated nuclear membranes, the choline
base exchange activity was also demonstrated [11]. Until now
no evidence is available on PC synthesis at the level of chro-
matin. The chromatin PC and SM in rat hepatocytes di¡er
from those of microsomes and nuclear membranes in turnover
[12] and percentage distribution [13]. Changes in the chroma-
tin PC and SM have been observed during cell maturation
[14]. The presence in chromatin of some enzymes related to
phospholipid (PL) metabolism, namely neutral sphingomye-
linase (N-SMase) [15], PC-dependent phospholipase C (PC-
PLC) [16] and SM-synthase [17] has been reported. These
enzymes can be distinguished from the other present in nu-
clear membranes on the basis of pH, Km and V/time relation-
ship. The aim of the present study was to investigate the
presence of reverse SM-synthase activity in nuclear membrane
and chromatin. The results show that this enzyme does occur
in chromatin, whereas it is almost undetectable in the nuclear
membrane. The presence of SM-synthase and reverse SM-syn-
thase in chromatin may have a relevant in£uence in regulating
the DAG/ceramide ratio at this particular subcellular level.
2. Materials and methods
The radioactive SM (choline-methyl-[14C], 54.5 Ci/mol) and PC
(L-3-phosphatidyl N-[3H]methyl-choline-1,2 dipalmitoyl, 81.0 Ci/
mmol) were obtained from NEN (Boston, MA, USA); Ecoscint A
was obtained from National Diagnostic (Atlanta, GA, USA); phen-
ylmethylsulfonyl £uoride (PMSF), PC, SM and PC-PLC were ob-
tained from Sigma (St. Louis, MO, USA).
Thirty-day-old Sprague^Dawley rats of either sex (Harlan Nossan,
Milano, Italy) were used. They were kept at a normal light^dark
period and had free access to pelleted food and water prior to killing
by cervical dislocation, after which the livers were quickly removed
and immediately processed.
2.1. Preparation of homogenate, cytosol, nuclei, chromatin and nuclear
membranes from rat liver
The liver was homogenized in a cold solution of 2.2 M sucrose, 3.3
mM CaCl2 in 1 mM PMSF adjusted to pH 7.2 with concentrated
Tris. The hepatocyte nuclei were prepared according to Bresnick et
al. [18] in the presence of 1 mM PMSF (Sigma, St. Louis, MO, USA).
as described previously [19]. After nuclei isolation, the cytosol was
removed and sodium deoxycholate (1% ¢nal concentration) was
added. The nuclei were then washed twice with Barnes et al. solution
[20]. The absence of contamination by the endoplasmic reticulum was
shown by electrophoretic analysis of RNA extracted from this prep-
aration [21]. The nuclear pellet still contains some rRNA which com-
pletely disappears after two washings in Barnes et al. solution [20].
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The nuclei were checked for possible cytoplasmic contamination also
by evaluating the activity of a microsomal marker (NADH-cyto-
chrome c-reductase) [11]. The swelling of nuclei and chromatin extrac-
tion were performed according to the method of Shaw and Huang
[22], modi¢ed by Viola Magni et al. [19]. Nuclear membranes were
isolated according to the procedure of Kay and Johnston [23].
2.2. Biochemical determinations
Protein, DNA and RNA contents were determined according to
Lowry et al. [24], Burton [25] and Schneider [26], respectively.
2.3. Lipid analysis
Lipids were extracted from homogenate, cytosol, nuclear membrane
and chromatin fractions with 20 volumes of chloroform/methanol
(2:1, v/v). The organic phase was washed with 0.2 volumes of 0.5%
NaCl according to Folch et al. [27]. The total amount of PLs was
determined, after lipid extraction, by measuring inorganic phosphorus
[28]. The SM was isolated by thin layer chromatography (TLC) [19]
and determined by measuring inorganic phosphorus [28]. The DAG
and ceramide contents were evaluated according to Rastegar et al. [29]
and Previati et al. [30], respectively.
2.4. Reverse SM-synthase activity assay
The reverse SM-synthase activity was assayed in homogenate, cy-
tosol, nuclear membrane and chromatin. In reaction 1 nmol of
[14C]SM was diluted by adding 49 nmol cold SM to a ¢nal radio-
activity of 1.08 Ci/mol.
Homogenate, cytosol and nuclear membranes. To establish the opti-
mal conditions of the assay, preliminary experiments were performed
changing the SM concentration from 0.05 and 0.6 mM, by the addi-
tion of proper amounts of 8Wmol/ml exogenous SM, and DAG con-
centration from 0.05 and 0.6 mM by the addition of proper amount of
6 Wmol/ml exogenous DAG, keeping a constant 0.5 mM SM concen-
tration. Also the pH was changed between 7.2 and 8.8. In the optimal
conditions, reaction mixture contained 0.1 M Tris^HCl pH 7.6, 0.5
mM [14C]SM, 0.5 mM DAG, 6 mM MgCl2, 0.1% Triton X-100 and
100 Wg of homogenate, cytosol or nuclear membrane proteins to a
¢nal volume of 0.2 ml. Incubation was performed at 37‡C for di¡erent
times until 90 min. The reaction was stopped by adding 2 ml chloro-
form/methanol (2:1, v/v); 0.4 ml of 0.5% NaCl was added to the tubes
under stirring. The tubes were centrifuged at 2000Ug for 10 min and
the upper phase was removed. The lower phase was dried under nitro-
gen £ow, the lipids were resuspended with chloroform and the radio-
active PC was evaluated as reported below.
Chromatin. To evaluate the optimal conditions of the assay, the SM
concentration was changed between 0.02 and 0.4 mM and DAG con-
centration between 0.02 and 0.3 mM, keeping a constant 0.3 mM SM
concentration; the exogenous SM and DAG were added as above
reported. Also the pH was changed between 7.2 and 8.8. In the opti-
mal conditions, reaction mixture contained 0.1 M Tris^HCl pH 8.4,
0.3 mM [14C]SM, 0.3 mM DAG, 6 mM MgCl2, 0.1% Triton X-100
and 100 Wg of chromatin proteins to a ¢nal volume of 0.2 ml. The
incubation was performed at 37‡C for di¡erent times until 90 min.
Further reaction conditions were the same as those reported above.
2.4.1. Identi¢cation of the product of enzyme action. The product
of the transferase reaction was identi¢ed as PC on the basis of:
(a) migration using authentic PC as standard by TLC on silica gel
60 (Merck, Darmstadt, Germany) plates and chloroform/methanol/
ammonia (65:25:4, v/v/v) as solvent. In the sample, exogenous cold
PC was added to the tubes before chromatography in order to identify
the spot. The PLs were localized with iodine vapor, scraped o¡ the
plates, put into counting vials and dispersed with 10 ml Ecoscint A
and 1 ml water. The radioactivity measurements were made with a
liquid scintillation analyzer (Packard Instrument Company, Meriden,
CT, USA). The radioactivity was recovered only in SM, used as re-
action substrate, and PC, product of the reaction. (b) degradation by
a speci¢c PLC. In order to evaluate if the radioactivity of the PC spot
disappears, the spots, corresponding to PC and SM, were scraped o¡
and the PLs were recovered by tree successive elutions with chloro-
form/methanol (2:1, v/v). The samples were treated with 1.1 U PC-
PLC (Sigma) at 37‡C for 15 min. Then, the lipids were again extracted
and the two fractions, inorganic and organic, were recovered. The
organic fraction was again chromatographed in order to verify the
presence of the spot which was considered to correspond to PC. The
radioactivity was recovered only in SM. The aqueous fraction was
chromatographed in order to evaluate the radioactivity carried by
PCh. PCh was identi¢ed, comparing with standard PCh, by TLC
using chloroform/methanol/ammonia/H2O (65:25:4:10, v/v/v/v) as
the solvent system [16]. The PCh was localized with iodine vapor,
scraped o¡ the plates, and counted as described above.
2.5. SM-synthase assay
The SM-synthase activity was detected according to the method of
Albi and Viola Magni [17], using [3H]PC as the source of [3H]PCh.
The pH of the reaction mixtures was 7.6 for homogenate, cytosol,
nuclear membrane, and 8.4 for chromatin.
3. Results
The puri¢cation level and the composition of nuclear mem-
branes and chromatin were similar to those previously re-
ported for 60-day-old rats [11^13,21]. The SM, DAG and
ceramide contents in the di¡erent cell fractions are reported
in Table 1. In the nuclear membrane, the SM content was 4.63
nmol/mg protein, 77% and 63% of that present in the homog-
enate and cytosol, respectively; in the chromatin, the value
was 1.5 nmol/mg protein. The ceramide and DAG contents
were 4.7- and 2.25-fold, respectively in nuclear membrane and
Table 1
Sphingomyelin (SM), ceramide (Cer) and diacylglycerol (DAG) con-
tents and the DAG/ceramide ratio in homogenate (H), cytosol (C),
nuclear membrane (NM) and chromatin (Chr)
H C NM Chr
SM 6.43P0.36 5.27P0.28 4.63P 0.32 1.50P 0.27
Cer 0.20P0.04 0.22P0.09 1.05P 0.03 1.99P 0.11
DAG 0.86P0.32 0.90P0.49 2.03P 0.21 3.37P 0.18
DAG/Cer 4.3 4.1 1.92 1.69
The values are expressed as nmol/mg protein and represent the
mean of three experimentsPS.D.
Fig. 1. Identi¢cation of the product of reverse SM-synthase. Mono-
dimensional TLC was performed using as solvent chloroform/metha-
nol/ammonia (65:25:4, v/v/v). A: standard PC and SM (from the
top); B: incubated sample; exogenous PC was added to the tubes
before chromatography to facilitate PC identi¢cation; C: the same
sample as B after PC-PLC treatment. The PC and SM spots corre-
sponding to PC and SM were scraped, eluted, and treated with 1.1
U PC-PLC at 37‡C for 15 min. After lipid extraction, the organic
fraction was again chromatographed as above in order to verify the
correct identi¢cation of PC spot. For details see Section 2.
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9.5- and 3.7-fold in chromatin than those present in homog-
enate and cytosol, respectively.
3.1. Identi¢cation of reverse SM-synthase product
For the identi¢cation of reverse SM-synthase product,
[14C]SM was used as donor substrate and DAG as the accep-
tor substrate. After the reaction, the PLs present in the incu-
bation medium were separated by monodimensional TLC.
Since the chromatin PC, present in 100 Wg protein, was 0.3
Wg, cold PC was added in order to better identify the spot and
the radioactivity was recovered in SM (27.720 cpm) and PC
(1386 cpm) spots (Fig. 1A,B). In order to con¢rm that the PC
spot contained really labelled PC, the labelled spots were
scraped o¡, solubilized and digested with PC-PLC. After lipid
extraction, the organic phase was again submitted to chroma-
tography where only the radioactive SM spot was present
(Fig. 1C), and the aqueous phase showed, after chromatog-
raphy, radioactive PCh as the only radioactive spot (Fig. 2).
Practically, all the radioactivity carried by formed PC was
recovered as PCh.
3.2. Quanti¢cation of reverse SM-synthase activity
The values of reverse SM-synthase activity in the di¡erent
subcellular fractions are reported in Fig. 3. In homogenate
cytosol and nuclear membrane the enzyme activity is ex-
tremely low, 0.93 P 0.14, 2.61 P 0.33 and 0.87 P 0.13 pmol/mg
protein/min, respectively, whereas in chromatin it is remark-
ably high, 37.09 P 2.05 pmol/mg protein/min. The enzyme has
a pH optimum of 8.4 (Fig. 4a), in agreement with previous
observations for other PLs enzymes [18^20]; the reaction is
linear with time till at least 90 min (Fig. 4c) and with respect
to the protein concentration in the range 50^300 Wg (Fig. 4b).
In the chromatin, where the DAG content is 3.07 nmol/mg
protein, enzymatic activity obeys a regular Michaelis^Menten
kinetics and the Km values are 3.56U1035 M for exogenous
SM (Fig. 4d) and 1.12U1034 M for exogenous DAG (Fig.
4e); the values of Vmax were 9.5 and 50 pmol/mg protein/min
for DAG and SM, respectively.
3.3. SM-synthase activity
In homogenate and cytosol the enzymatic activity of SM-
synthase is 25.91 P 0.06 and 16.20P 0.13 pmol/mg protein/min,
respectively. In nuclear membranes the enzymatic activity is
770.09P 55.86 pmol/mg protein/min and in chromatin
278.17P 28.39 pmol/mg protein/min.
The ratio between SM-synthase and reverse SM-synthase in
the di¡erent subfractions is reported in Table 2.
4. Discussion
This paper provides for the ¢rst time evidence for the oc-
currence of reverse SM-synthase in the chromatin of rat liver.
Pagano et al. [31] have shown by using £uorescent method
that C6NBP phosphatidic acid may be converted in the cy-
toplasm of ¢broblast to DAG coupled with CDP-choline for
the synthesis of PC. The £uorescent PC labels the plasmatic
membranes, and the nuclear membranes, thus con¢rming that
the synthesis of PC in the nuclear membrane is mostly due to
the Kennedy pathway [31]. No label was demonstrated inside
the nucleus. Our results have shown the presence of PLs in the
chromatin, the great part of which is represented by PC. The
possibility that PC can be transported by speci¢c protein in-
side the nucleus cannot be excluded, as well as that other
minor pathways may be used for its synthesis. The complex
of base exchanges has been detected in nucleus [11]. It has
Fig. 2. Identi¢cation of PCh. Monodimensional TLC was performed
using as solvent chloroform/methanol/ammonia/H2O (65:25:4:10,
v/v/v/v). 1: PCh standard; 2: PCh separated from the sample.
Fig. 3. Reverse SM-synthase activity. The activity of reverse SM-synthase was determined at optimal conditions as reported in Section 2. The
data are the meanPS.D. of tree separate experiments.
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been shown that the content of PC may change inside the
nucleus in many physiological situations, suggesting some rap-
id mechanisms with respect to the transport from the cyto-
plasm. The presence of reverse SM-synthase may induce quick
modi¢cations of intranuclear ceramide and DAG contents in
relation to the enzyme activity which may be counterbalanced
by the SM-synthase activity. Actually there is no su⁄cient
information in order to establish if SM-synthase and reverse
SM-synthase are the same enzyme or two di¡erent enzymes. It
must be taken into account that SM-synthase activity in the
chromatin is 7.5 times higher than that of reverse SM-syn-
thase. This ratio increases in nuclear membrane in which the
activity of reverse SM-synthase is very low, thus suggesting
that the PC synthesis may be due to the other enzymatic
reaction. This di¡erence may have in£uence on the DAG/cer-
amide ratio, which is lower in chromatin, thus suggesting a
possible utilization of DAG for PC-synthesis.
Many roles have been attributed to ceramide, either in cell
growth and di¡erentiation [32,33] or in apoptotic processes
[34]. Most of these researches concerns the cellular pathways
Fig. 4. Reverse SM-synthase activity in the chromatin. a: E¡ect of pH on the enzyme activity; b: V/enzyme course; c: V/time course;
d: V/SM substrate concentration; e: V/DAG substrate concentration. The data are the meanPS.D. of three separate experiments.
Table 2
The SM-synthase/reverse SM-synthase ratio in homogenate (H), cytosol (C), nuclear membrane (NM) and chromatin (Chr)
H C NM Chr
SM-synthase/reverse SM-synthase 27.86 6.20 885.05 7.49
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of SM and the increase of cytosolic ceramide. The target of
this second messenger is considered to be the protein kinase
C, which is activated by DAG and inhibited by ceramide and
sphingosine [35]. This e¡ect is evident on cytosolic kinase,
whereas an opposite e¡ect is observed on the protein kinase
associated to the membranes, as shown in cells treated with
TNFK [36]. Recently an increase in ceramide was observed in
hepatocyte nuclei after lobular ligation [37], a situation which
induces apoptotic modi¢cations of hepatocytes. In our case it
cannot be excluded that the intranuclear ceramide increase
blocks the cells in G1 by inhibiting enzymes, such as DNA
primase, or favoring the aggregation of chromatin as an initial
apoptotic event. On the other hand, it may be equally sup-
posed that the activation of nuclear membrane kinase by cer-
amide may favor the phosphorylation of phosphoproteins re-
lated to the cell cycle, thus favoring cell proliferation.
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